Cannabis Stock News- Investing in Cannabis and Hemp Stocks

Wednesday, May 23, 2018

Investor Ideas ‘Potcast’; #Cannabis News and Stocks on the Move; TSXV: $EMH.V, TSXV: $ABCN.V, TSXV: $SPN.V

Investor Ideas ‘Potcast’; #Cannabis News and Stocks on the Move; TSXV: $EMH.V, TSXV: $ABCN.V, TSXV: $SPN.V

Pt. Roberts, WA; Delta, BC –May 23, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of

its new series, Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

http://www.investorideas.com/Audio/Podcasts/2018/052318-StocksToWatch.mp3

Read this in full at http://www.investorideas.com/news/2018/cannabis/05231Potcast-TSXVEMHABCNSPN.asp

Today’s podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com potcast – looking at cannabis news, stocks to watch as well as insights from thought leaders and experts. Today we are looking at announcements from Emerald Health Therapeutics, Inc. (TSXV:EMH) .ABcann Global Corporation (TSXV: ABCN) and Snipp Interactive Inc. (TSXV: SPN, OTCQB :SNIPF) .

First looking at Emerald Health Therapeutics, Inc. who closed its prospectus sale to a single Canadian institutional accredited investor. Pursuant to the Offering, the Company has issued 4,000,000 units at a price per Unit of $4.20 for gross proceeds of $16,800,000.

The Company intends to use the net proceeds of the Offering to fund the completion of its recently acquired Agro-Biotech facility in Quebec, for working capital, and for general corporate purposes.

ABcann Global Corporation announced the launch of Beacon Medical, its new medical cannabis brand. The goal of Beacon Medical is to help patients and their healthcare providers navigate the complex medical cannabis market to find the best treatment option.

“Our vision is to leverage our unique experience in the global pharmaceutical industry to create one of the most respected medical cannabis companies. The launch of Beacon is an important step towards that vision,” stated Barry Fishman, Chief Executive Officer.

ABcann’s study conducted on 1,500 Canadians identified that 73% of adult Canadians who are not currently using cannabis, but have a treatable condition, say they lack the appropriate knowledge of how to use medical cannabis, and 67% say they are unfamiliar with how to obtain medical cannabis. With so many Canadians not clear about how to obtain and use medical cannabis, ABcann believes the market is ready for a brand that makes the process easier to navigate.

Beacon Medical will differentiate itself by focusing on the patient experience: simple registration and product classification, efficient purchasing, pharmaceutical-grade products, and compassionate customer service.

Beacon Medical invites investors, media and consumers to get a first glimpse of the new Beacon brand at the Lift Expo taking place in Toronto from May 25^th to 27^th, 2018. The full Beacon Medical website and product line, which will include the introduction of cannabis oils, will be available to ACMPR patients by early summer 2018.

Finally looking at Snipp Interactive Inc. a global provider of digital marketing promotions, rebates and loyalty solutions, today announced that it has signed a Master Services Agreement with CLS HOLDINGS USA, who is in the process of finalizing its purchase of Oasis Cannabis a "seed to sale" company focusing on Cultivation, Production and Dispensaries. CLS showed interest in Snipp’s solutions by signing up on its recently launched Cannabis Marketing Resource Center (“CMRC”).

In addition, CLS is the developer of a proprietary patent-pending extraction and conversion methodology that has potential to increase yield and quality of cannabinoid oils extracted from cannabis plants.

Snipp will, pursuant to the MSA, implement a customer retention and management platform covering all CLS locations across Snipp’s, SnippCheck, SnippRewards and SnippLoyalty platforms. Snipp will leverage the accumulated knowledge and deep expertise it has acquired in designing and launching marketing programs in other highly regulated industries like Pharma, Alcohol and tobacco to help CLS run effective and legally compliant promotion and loyalty programs to meet their marketing objectives.

“We have explored a number of loyalty platforms and after extensive review and consultation with Snipp have concluded that Snipp’s robust and highly flexible platform allows us to deploy a system that we can leverage as we grow the CLS platform” said Jeff Binder, CEO of CLS.

Investor ideas reminds all listeners to read our disclaimers and disclosures
on the Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment

Subscribe to the new cannabis podcast series:

http://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit http://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.

Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

To sponsor this podcast or be a guest

Contact Investorideas.com

http://www.investorideas.com/About/Contact.asp

800-665-0411

Marijuana / Hemp Stocks at Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news

Tuesday, May 22, 2018

Investorideas.com - New Frontier Data Downgrades #CA #Cannabis Sales Projections by $2 Billion

Investor Ideas ‘Potcast’; #Cannabis News and Stocks on the Move; (TSX: $ACB.TO), (CSE: $ATT.C), (TSXV: $ICC.V), (TSX: $TGOD.TO)

Investor Ideas ‘Potcast’; #Cannabis News and Stocks on the Move; (TSX: $ACB.TO), (CSE: $ATT.C), (TSXV: $ICC.V), (TSX: $TGOD.TO)

New Frontier Data Adjusts CA Projections

Pt. Roberts, WA; Delta, BC – May 22, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of

its new series, Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

http://www.investorideas.com/Audio/Podcasts/2018/052218-StocksToWatch.mp3

Read this in full at http://www.investorideas.com/news/2018/cannabis/05222Potcast-StocksToWatch.asp

Today’s podcast overview/transcript:

Good afternoon and welcome to Investorideas.com potcasts- following cannabis news, stocks to watch as well as insight from thought leaders and experts . Today we are looking at announcements from Aurora Cannabis Inc. (TSX : ACB , OTCQB: ACBFF), Abattis Bioceuticals Corp. (CSE: ATT ,OTC: ATTBF), ICC Labs Inc. (TSX-V: ICC ) and The Green Organic Dutchman Holdings Ltd. (TSX: TGOD).

Before the other announcements however we look at New Frontier Data, the authority in data, analytics and business intelligence in the cannabis industry, has refined the state market projections for California in light of the state’s recent lower than expected cannabis excise-tax revenues for the first quarter of 2018. The state collected $33.6 million between January 1 and March 31, which put them significantly below the original of $175 million within the first six months of 2018. New Frontier Data has reduced the latest sales projections for 2018 from $3.8 billion to $1.9 billion. And by 2025, our forecast for total California sales to be $4.72 billion instead our previously projected $6.7 billion.

New Frontier Data looked at two key aspects of the California market; their analysts redefined what a legal medical patient is and lowered the conversation rate for illicit market consumers transitioning to legal adult-use market consumers.

Next looking at Aurora Cannabis Inc. and CTT Pharmaceutical Holdings Inc. who today announced that Aurora is acquiring an initial 9.14% ownership interest in CTT via way of a non-brokered private placement in the form of a US$1 million 5% convertible debenture. The agreement includes an issuance of warrants enabling Aurora to increase ownership to 42.5%.

CTT will now provide Aurora with global exclusivity to develop, manufacture and market CTT’s novel oral thin films wafers. The companies will work jointly towards obtaining Health Canada approval for introduction of the new products on the Canadian market, as well as obtaining commercial access to other international jurisdictions in which Aurora is active.

A little about CTT; they’re an Ontario based global leader in the development of dose specific fast dissolving oral thin film wafers that provide a dose specific, smoke-free delivery of medical cannabis or other active ingredients. CTT’s oral thin film wafer is made from FDA approved non-medical ingredients used in several pharmaceutical formulations and provides the effective oral delivery of a specific dose with rapid onset of action within 5-10 minutes after dosing. Clinical research undertaken by CTT indicates the oral wafer delivery of THC into the blood steam was approximately 40% quicker compared to edible form factors, as well as resulted in approximately 28% more THC in the blood stream at peak bioavailability levels.

Abattis Bioceuticals Corp. announced the addition of three new vaporizers to its product line today. Since the Company’s acquisition of Green Tree Therapeutics earlier this year, Abattis has been working to expand its retail presence and product line and is now ready to release its first three vaporizers, the VB-1, VB-2 and the KB-1.

”We believe that the future of the cannabis vaporizer market is in branding, concentrates and ancillary products,” stated Rob Abenante, President and CEO of Abattis. “Users in the retail space are looking for functional, discreet and durable products and we feel that our new titillating product line will meet all these demands. In this, we are excited to take another step towards our goal of becoming a complete one-stop provider of downstream cannabis solutions,” added Mr. Abenante.

ICC Labs Inc. announced that it has signed a letter of intent with CanPharma GmbH a licensed importer and wholesaler of narcotics in the Federal Republic of Germany.

Through its relationship with CanPharma, ICC Labs intends to export to Germany CBD isolate, oils and other derivatives, as well as various medicinal THC cannabis products, including dried flowers and cannabis extracts from their facilities in Uruguay and Colombia. The export arrangement for THC cannabis products is subject to receipt of the requisite regulatory approvals and the negotiation of definitive agreements by the end of second quarter this year.

Germany, with a population of 83 million people, €3.3 trillion in GDP and €320 billion of healthcare expenditure, is home to Europe’s largest medical cannabis market. Germany is already leading the way among European countries with a market value of US$11.9 billion.⁽¹⁾

Finally looking at The Green Organic Dutchman Holdings Ltd. who announced that the Company has entered into an exclusive agreement with CBx Enterprises LLC for the licensing of the Evolab and CBx Sciences brands and proprietary technologies and formulations within Canada and other international jurisdictions outside of the USA.

Based in Colorado, the CBx team brings decades of experience developing and marketing a diverse array of unique, first-to-market medical and recreational cannabis products. The licensing arrangement will immediately expand TGOD’s product and technology portfolio, and position the Company for the successful development of new products as Canadian and global product requirements and standards rapidly evolve.

Evolab is a top cannabinoid vaporization brand that has gained significant market share through the creation of highly differentiated products in a very competitive and saturated market. Evolab’s proprietary technologies and industry-leading extraction efficiencies allow for the derivation of pharmaceutical-grade cannabinoid oils and strain-specific terpenes without the use of any harmful solvents or cutting-agents. These technologies and formulations lead to the creation of much cleaner and safer full-plant oils for vaporization without the introduction of chemicals commonly found in the e-vape industry.

Subscribe to the new cannabis podcast series:

http://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit http://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.

To sponsor this podcast or be a guest

Contact Investorideas.com

http://www.investorideas.com/About/Contact.asp

800-665-0411

Marijuana / Hemp Stocks at Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news

Monday, May 21, 2018

Investor Ideas ‘Potcast’; #Cannabis News and Stocks on the Move; CSE: $LILY.C, OTCQB: $MPHMF, OTC: $NGTIF, OTCQB: $CLSH

Pt. Roberts, WA; Delta, BC May 21, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of

its new series, Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

http://www.investorideas.com/Audio/Podcasts/2018/052118-StocksToWatch.mp3

Read this in full at http://www.investorideas.com/news/2018/cannabis/05211Potcast-StocksToWatch.asp

Today’s podcast overview/transcript:

Good afternoon and welcome to Investorideas.com potcasts- following cannabis news, stocks to watch as well as insight from thought leaders and experts . Today we are looking at announcements from Callitas Health Inc trading on the CSE as LILY and OTCQB as MPHMF, Nightfood Holdings Inc trading on the OTC as NGTF and CLS Holdings USA, Inc. trading on the OTCQB under CLSH.

First looking at Callitas Health Inc a clinical-stage pharmaceutical development and OTC consumer goods marketing company, who announced earlier today that it has signed industry expert Dr. Gregory Smith MD, MPH, as the Company’s Chief Medical Cannabis Advisor. The addition of Dr. Smith is expected to help give the Company additional product development, clinical study capabilities and visibility in the THC/CBD (cannabinoids) market.

“We believe the addition of Dr. Smith to the Callitas team will help us better navigate the quickly evolving cannabinoid industry and provide expert insight for our current products and future programs in research and development,” said James Thompson, Interim President and CEO. “He brings a wealth of knowledge, clinical experience and insights that will be invaluable for our Company’s growth.”

Dr. Smith has garnered extensive experience and education in the field of cannabinoid medication, and currently serves as the editor-in-chief of www.Cannabis-MD.com, and Director of Medical Affairs for First Harvest Financial, Inc. (a cannabis investment firm).

Next looking at NightFood Holdings, Inc. a brand development company pioneering the projected billion dollar nighttime nutrition category, and developing unique properties and products in the marijuana/cannabis/CBD related snack space, today announced that the first production run of Half-Baked™ branded products has been successfully completed under license in the State of California.

The Half-Baked brand THC-infused cookies each contain 10mg of THC and will retail for approximately $5. As originally announced on April 20, 2018, the product is on track to be available at retail before the end of May.

“This is the birth of a leading national edibles brand in the marijuana space. That’s how we view this initial production run and pilot launch,” commented CEO Sean Folkson. “As more states continue to follow suit and pass marijuana legislation, we see an increase in the value of the opportunity and in the value of the Half-Baked intellectual property.”

Plans are for the Half-Baked brand to include regular snacks that would be legal and immediately eligible for national distribution, as they’d contain no THC or cannabis in any form, in addition to lines of cannabis-containing snacks.

Subsequent to filing the Half-Baked trademark application in January, the Company acquired HalfBaked.com. In the coming months, the Company intends to launch the HalfBaked.com website to support the launch and development of this leading consumer cannabis brand.

An investor conference call is being coordinated for the week of May 28, 2018, during which the Company will provide updates on revenues, new product development, and other recent activities. An announcement will be made prior to the call providing investors all details necessary to attend the call and submit questions for management.

Finally, looking at CLS Holdings USA, Inc. a development stage diversified cannabis company operating as Cannabis Life Sciences, today announced that its proposed acquisition of Oasis Cannabis has progressed and is now expected to close by the end of June 2018.

The parties mutually agreed to extend the purchase agreement to June 21, 2018. This extension timeline remains in the initial expectation of closing by the end of the second quarter 2018. The extension is due to additional time needed to complete certain license transfer documentation.

Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. The company recently commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products in August 2017. An expansion of its cultivation and production facility is currently underway and is expected to be completed during the second half of 2018.

CLS Holdings USA, Inc. plans to become a diversified cannabis company and is shifting its corporate strategy to becoming a fully licensed integrated cannabis producer and retailer in Nevada and other states.

CLS stands for "Cannabis Life Sciences," in recognition of the Company's patent pending proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

Subscribe to the new cannabis podcast series:

http://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit http://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.

To sponsor this podcast or be a guest

Contact Investorideas.com

http://www.investorideas.com/About/Contact.asp

800-665-0411

Marijuana / Hemp Stocks at Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news

Friday, May 18, 2018

Investorideas.com - Viridian to Moderate Institutional Investor Panel at The #MedMen Institutional Capital & #Cannabis Conference in Los Angeles

Investorideas.com - Viridian to Moderate Institutional Investor Panel at The #MedMen Institutional Capital & #Cannabis Conference in Los Angeles

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investor Ideas ‘Potcast’; Interview with #MS survivor Montel Williams, one of the highest-profile medical #cannabis patients in the U.S. @Montel_Williams

Investor Ideas ‘Potcast’; Interview with #MS survivor Montel Williams, one of the highest-profile medical #cannabis patients in the U.S. @Montel_Williams

Pt. Roberts, WA; Delta, BC –May 18, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of

its new series, Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts.

In this special edition podcast Investor Ideas talks to Montel Williams, one of the highest-profile medical cannabis patients in the U.S. He discusses the Lenitiv’s hemp-derived CBD Capsules, a product he developed and formulated and how it has helped him deal with pain over the years. He also talks about the path to legalization globally over the next five to ten years and his long term vision for the industry.

He shares his big ambition to host a panel and forum with the U.N. and open up cannabis discussions with the world.

This interview follows recent news that Cura, a leading provider of cannabis oil, has reached an agreement to produce a hemp-derived and a cannabis-derived line for Lenitiv.

Full news: http://www.investorideas.com/news/2018/cannabis/05171Lenitiv.asp

Read in full at http://www.investorideas.com/news/2018/cannabis/05182Potcast-MontelWilliams.asp

Listen to the podcast:

http://www.investorideas.com/Audio/Podcasts/2018/051818-MontelWilliams.mp3

Today’s podcast overview/transcript:

ABOUT LENITIV SCIENTIFIC

Founded in 2016 by Montel Williams, Melanie McLaughlin and David Racz to make sure the needs of medical cannabis patients continue to be met in an increasingly adult-use market, Lenitiv is a premium brand that offers both hemp-derived CBD products nationwide and cannabis-derived products in Oregon, California and Nevada later this summer. Unlike many other “celebrity brands,” Williams is actively involved in Lenitiv, including as its chief formulator, taking advantage of his nearly two decades as a patient himself. Learn more at www.lenitivlabs.com

ABOUT CURA

Cura Cannabis Solutions is one of the largest cannabis brands in America, on a mission to be the leading provider of cannabis oil in legal U.S. and international markets. Our goal is to provide patients and customers with the cleanest, most flavorful high quality cannabis oils, with the safest delivery method available. Makers of the Select Oil and Select CBD brands, Cura was established in Portland, Oregon in 2015 and in 2018, we were named #12 on Oregon Business Magazine’s list of the Top 100 Companies to Work For in Oregon. We expanded into California and Nevada in 2017, with new states on the horizon in 2018. Learn more at: www.curacan.com

Subscribe to the new cannabis podcast series:

http://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit http://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.

To sponsor this podcast or be a guest

Contact Investorideas.com

http://www.investorideas.com/About/Contact.asp

800-665-0411

Marijuana / Hemp Stocks at Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news

about Investorideas.com

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .